US Stock MarketDetailed Quotes

IKT Inhibikase Therapeutics

Watchlist
  • 2.0500
  • -0.3100-13.14%
Close Nov 15 16:00 ET
  • 2.0700
  • +0.0200+0.98%
Post 19:14 ET
137.74MMarket Cap-657P/E (TTM)

Inhibikase Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-18.57%5.05M
1.43%4.78M
10.82%20.09M
1.58%4.4M
5.67%4.77M
33.67%6.2M
1.60%4.71M
22.77%18.13M
-14.01%4.33M
0.94%4.51M
Selling and administrative expenses
10.74%1.97M
5.49%2.03M
8.28%6.73M
4.18%1.4M
5.47%1.62M
7.14%1.78M
15.32%1.93M
-4.47%6.22M
-18.68%1.34M
-6.46%1.54M
Research and development costs
-32.19%3.08M
-3.60%2.75M
13.16%13.62M
-1.68%3M
8.18%3.23M
52.09%4.54M
-5.40%2.85M
5.95%12.03M
-9.91%3.05M
-5.48%2.98M
Other operating expenses
----
----
-111.03%-260.5K
100.00%-1
-991.33%-79.57K
-1,676.71%-116.41K
-40.17%-64.52K
96.02%-123.44K
-3,169.86%-63.57K
97.78%-7.29K
Operating profit
18.57%-5.05M
-1.43%-4.78M
-10.82%-20.09M
-1.58%-4.4M
-5.67%-4.77M
-33.67%-6.2M
-1.60%-4.71M
-22.77%-18.13M
14.01%-4.33M
-0.94%-4.51M
Net non-operating interest income expense
-78.58%90.93K
-44.04%132.73K
1,324.94%1.06M
303.47%225.63K
836.97%173.68K
424.44K
4,743,520.00%237.17K
473.70%74.45K
35,493.67%55.92K
11,906.37%18.54K
Non-operating interest income
-78.58%90.93K
-44.04%132.73K
1,324.94%1.06M
303.47%225.63K
836.97%173.68K
--424.44K
--237.17K
--74.45K
--55.92K
--18.54K
Other net income (expense)
Income before tax
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
Income tax
Net income
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
Net income continuous Operations
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
Minority interest income
Net income attributable to the parent company
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
-0.52%-4.49M
Basic earnings per share
29.79%-0.66
25.51%-0.73
16.59%-3.57
37.25%-0.64
18.87%-0.86
14.55%-0.94
9.26%-0.98
11.93%-4.28
15.00%-1.02
1.85%-1.06
Diluted earnings per share
29.79%-0.66
25.51%-0.73
16.59%-3.57
37.25%-0.64
18.87%-0.86
14.55%-0.94
9.26%-0.98
11.93%-4.28
15.00%-1.02
1.85%-1.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -18.57%5.05M1.43%4.78M10.82%20.09M1.58%4.4M5.67%4.77M33.67%6.2M1.60%4.71M22.77%18.13M-14.01%4.33M0.94%4.51M
Selling and administrative expenses 10.74%1.97M5.49%2.03M8.28%6.73M4.18%1.4M5.47%1.62M7.14%1.78M15.32%1.93M-4.47%6.22M-18.68%1.34M-6.46%1.54M
Research and development costs -32.19%3.08M-3.60%2.75M13.16%13.62M-1.68%3M8.18%3.23M52.09%4.54M-5.40%2.85M5.95%12.03M-9.91%3.05M-5.48%2.98M
Other operating expenses ---------111.03%-260.5K100.00%-1-991.33%-79.57K-1,676.71%-116.41K-40.17%-64.52K96.02%-123.44K-3,169.86%-63.57K97.78%-7.29K
Operating profit 18.57%-5.05M-1.43%-4.78M-10.82%-20.09M-1.58%-4.4M-5.67%-4.77M-33.67%-6.2M-1.60%-4.71M-22.77%-18.13M14.01%-4.33M-0.94%-4.51M
Net non-operating interest income expense -78.58%90.93K-44.04%132.73K1,324.94%1.06M303.47%225.63K836.97%173.68K424.44K4,743,520.00%237.17K473.70%74.45K35,493.67%55.92K11,906.37%18.54K
Non-operating interest income -78.58%90.93K-44.04%132.73K1,324.94%1.06M303.47%225.63K836.97%173.68K--424.44K--237.17K--74.45K--55.92K--18.54K
Other net income (expense)
Income before tax 14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M
Income tax
Net income 14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M
Net income continuous Operations 14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M
Minority interest income
Net income attributable to the parent company 14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M-0.52%-4.49M
Basic earnings per share 29.79%-0.6625.51%-0.7316.59%-3.5737.25%-0.6418.87%-0.8614.55%-0.949.26%-0.9811.93%-4.2815.00%-1.021.85%-1.06
Diluted earnings per share 29.79%-0.6625.51%-0.7316.59%-3.5737.25%-0.6418.87%-0.8614.55%-0.949.26%-0.9811.93%-4.2815.00%-1.021.85%-1.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data